Literature DB >> 33301895

circSLC8A1 sponges miR-671 to regulate breast cancer tumorigenesis via PTEN/PI3k/Akt pathway.

Qin Zhu1, Xian Zhang2, Hong-Yan Zai1, Wei Jiang1, Ke-Jing Zhang3, Yu-Qiong He1, Yu Hu4.   

Abstract

Breast cancer is the most frequently diagnosed and the leading cause of cancer-related deaths in women worldwide. However, the role of circSLC8A1 in breast cancer remains elusive. Herein, a cohort of 77 breast tumors and paired adjacent normal mammary tissues were collected. We demonstrated that circSLC8A1 was significantly down-regulated in breast cancer tissues and cell lines, of which expression was negatively correlated with clinical severity and dismal prognosis. Overexpression of circSLC8A1 suppressed cell proliferation, migration and invasion in vitro, and inhibited tumor growth in vivo. CircSLC8A1 directly targeted miR-671 to execute tumor suppressive activities via regulating PI3k/Akt signaling. Krüppel-like factor 16 (KLF16), a transcriptional activator of PTEN, was identified as a target of miR-671. Furthermore, circSLC8A1 could sponge miR-671 to suppress breast tumor growth via PTEN/PI3k/Akt signaling in vivo. In summary, circSLC8A1/miR-671 regulates breast cancer progression through PTEN/PI3k/Akt signaling, which may provide efficient therapeutic target for this devastating cancer.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; KLF16; PTEN; circSLC8A1; miR-671

Mesh:

Substances:

Year:  2020        PMID: 33301895     DOI: 10.1016/j.ygeno.2020.12.006

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  7 in total

1.  Mechanical strain regulates osteoclastogenesis via modulating the PTEN/PI3K/Akt signal pathway through miR-21.

Authors:  Bin Fang; Kailong Zhang; Jie Zhang; Zhenda Chen; Yunxin Xuan; Hongbin Huang
Journal:  Cytotechnology       Date:  2021-11-22       Impact factor: 2.058

2.  STING agonist enhances the efficacy of programmed death-ligand 1 monoclonal antibody in breast cancer immunotherapy by activating the interferon-β signalling pathway.

Authors:  Mingming Yin; Jinlong Hu; Zhongxu Yuan; Guangyi Luo; Jiaming Yao; Rundong Wang; Dongquan Liu; Baoqiang Cao; Wenyong Wu; Zhiqi Hu
Journal:  Cell Cycle       Date:  2022-02-07       Impact factor: 5.173

Review 3.  CircNCX1: the "Lord of the Ring" in the Heart - Insight into Its Sequence Characteristic, Expression, Molecular Mechanisms, and Clinical Application.

Authors:  Lin Ding; Mengyang Li; Fuqing Yang; Jianxun Wang
Journal:  J Cardiovasc Transl Res       Date:  2021-10-12       Impact factor: 3.216

4.  Energy restriction induced SIRT6 inhibits microglia activation and promotes angiogenesis in cerebral ischemia via transcriptional inhibition of TXNIP.

Authors:  Ming-Yu Song; Fang Yi; Hui Xiao; Jun Yin; Qing Huang; Jian Xia; Xiao-Meng Yin; Yan-Bin Wen; Le Zhang; Yun-Hai Liu; Bo Xiao; Wen-Ping Gu
Journal:  Cell Death Dis       Date:  2022-05-11       Impact factor: 9.685

Review 5.  Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.

Authors:  Asal Jalal Abadi; Ali Zarrabi; Mohammad Hossein Gholami; Sepideh Mirzaei; Farid Hashemi; Amirhossein Zabolian; Maliheh Entezari; Kiavash Hushmandi; Milad Ashrafizadeh; Haroon Khan; Alan Prem Kumar
Journal:  Biomolecules       Date:  2021-02-18

6.  Association between microRNA 671 polymorphisms and the susceptibility to soft tissue sarcomas in a Chinese population.

Authors:  Peng Zhang; Xinling Li; Lingling Huang; Fulan Hu; Xiaoying Niu; Yang Sun; Weitao Yao
Journal:  Front Oncol       Date:  2022-08-09       Impact factor: 5.738

Review 7.  Circular RNAs as Potential Biomarkers in Breast Cancer.

Authors:  Fatima Domenica Elisa De Palma; Francesco Salvatore; Jonathan G Pol; Guido Kroemer; Maria Chiara Maiuri
Journal:  Biomedicines       Date:  2022-03-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.